Schedule M Draft Sets Zero Microbial Growth for Sterile Drugs
Health Ministry proposes Schedule M changes requiring zero microbial growth in Grade A sterile drug areas, aligning Indian GMP rules with WHO TRS 1044.
Health Ministry proposes Schedule M changes requiring zero microbial growth in Grade A sterile drug areas, aligning Indian GMP rules with WHO TRS 1044.
Union Health Ministry proposes immediate suspension of drug manufacturing licences for NSQ findings on assay, dissolution, impurities or sterility.
Regulators have stopped Sun Pharma from making and selling eye-care drugs from its Assam plant over quality system failures, with 332 recalled batches under review.
In a 27 October notice, DCGI Rajeev Raghuvanshi has asked state and UT drug regulators to make manufacturers test every batch of raw materials, critical excipients such as propylene glycol, glycerol and sorbitol, and finished products, and to enforce vendor qualification after inspections found lapses.